Federated Hermes’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.62K Hold
3,015
﹤0.01% 1923
2025
Q4
$2.96K Hold
3,015
﹤0.01% 1942
2025
Q3
$3.8K Buy
+3,015
New +$3.25K ﹤0.01% 1968
2025
Q2
Sell
-5,942
Closed -$4.69K 2102
2025
Q1
$4.69K Sell
5,942
-537,079
-99% -$658K ﹤0.01% 1883
2024
Q4
$896K Sell
543,021
-10,079
-2% -$25.4K ﹤0.01% 1138
2024
Q3
$1.94M Sell
553,100
-478,405
-46% -$1.86M ﹤0.01% 938
2024
Q2
$3.38M Buy
1,031,505
+24,127
+2% +$106K 0.01% 800
2024
Q1
$7.39M Sell
1,007,378
-842,494
-46% -$5.21M 0.02% 634
2023
Q4
$6.92M Sell
1,849,872
-601,672
-25% -$1.42M 0.02% 645
2023
Q3
$5.2M Sell
2,451,544
-17,755
-0.7% -$58.8K 0.01% 686
2023
Q2
$11.8M Buy
2,469,299
+806,978
+49% +$4.45M 0.03% 507
2023
Q1
$9.48M Buy
1,662,321
+1,086,805
+189% +$6.56M 0.02% 558
2022
Q4
$5.81M Buy
575,516
+450,513
+360% +$8.46M 0.02% 654
2022
Q3
$2.8M Sell
125,003
-12,416
-9% -$359K 0.01% 814
2022
Q2
$3.41M Buy
137,419
+12,419
+10% +$343K 0.01% 786
2022
Q1
$4.85M Hold
125,000
0.01% 791
2021
Q4
$7.31M Hold
125,000
0.01% 737
2021
Q3
$7.41M Hold
125,000
0.01% 728
2021
Q2
$10.8M Sell
125,000
-74,785
-37% -$6.03M 0.02% 626
2021
Q1
$16.5M Sell
199,785
-52,816
-21% -$5.06M 0.03% 540
2020
Q4
$23M Sell
252,601
-18,657
-7% -$1.16M 0.05% 435
2020
Q3
$10.8M Sell
271,258
-94,794
-26% -$3.31M 0.03% 552
2020
Q2
$12.6M Sell
366,052
-98,462
-21% -$2.93M 0.03% 490
2020
Q1
$10.3M Buy
+464,514
New +$11.7M 0.03% 468
2019
Q3
Sell
-237,317
Closed -$4.82M 2230
2019
Q2
$4.82M Sell
237,317
-221,552
-48% -$3.99M 0.01% 792
2019
Q1
$8.06M Buy
458,869
+109,118
+31% +$1.72M 0.02% 640
2018
Q4
$4.49M Buy
349,751
+99,287
+40% +$1.38M 0.01% 768
2018
Q3
$4.08M Buy
+250,464
New +$2.96M 0.01% 869
2018
Q2
Sell
-101
Closed -$1K 2221
2018
Q1
$1K Sell
101
-351
-78% -$3.36K ﹤0.01% 2096
2017
Q4
$3K Buy
+452
New +$2.02K ﹤0.01% 2038
2017
Q2
Sell
-1,170
Closed -$5K 2144
2017
Q1
$5K Buy
+1,170
New +$4.28K ﹤0.01% 1931

Other funds holding FATE